ellular and molecular research moves between scales: a sequence, a molecule, a cell and a larger biological system. A result at one scale does not automatically establish what happens at another. This guide explains the connections and provides a way to record exactly what a paper observed.
DNA and RNA describe different parts of the record
DNA biology concerns the storage, organisation and use of genetic information. RNA biology includes the production, processing and functions of RNA molecules. Molecular biology studies these and other molecular processes in living systems. Gene regulation concerns how the timing or amount of gene activity is controlled.
A DNA sequence, an RNA abundance measurement and a protein assay are different data types. Keep their identifiers and methods separate. If an article reports a change in RNA, do not silently rewrite the conclusion as a change in protein activity. The gene-expression guide develops this distinction with a reading example.
Transcription, translation and RNA processing
Transcription produces RNA using a DNA template; translation uses messenger RNA information to make a protein chain. Transcription regulation and translation regulation therefore act at different stages. RNA processing changes an RNA molecule as it matures. RNA splicing joins selected segments after intervening regions are removed, allowing some genes to produce different transcript forms.
Messenger RNA research needs a specific transcript identity, not just a familiar gene name. Check which form an assay detects and whether the authors distinguish multiple transcripts. An increase in one transcript does not establish that all forms changed together.
Epigenetic changes and chromatin
Epigenetics research examines changes in gene activity associated with features beyond the underlying DNA-letter sequence. DNA methylation and histone modification are two classes of chemical modification studied in this field. Chromatin biology concerns DNA and its associated proteins; epigenetic regulation connects these features with control of gene activity.
A modification is an observation whose meaning depends on its location and context. Avoid treating every increase in methylation as the same biological event. A study comparing cell types also needs to consider whether the apparent signal reflects a different mixture of cells. An epigenetic measurement is not automatically an ageing test or a treatment target.
Cells, cell lines and experimental models
Cell biology examines cellular organisation and processes. Cell models represent selected aspects of a biological system under defined conditions; cellular research uses those models to ask specific questions. Cell culture research maintains cells outside their original organism, making some conditions easier to control while changing others.
Record the model's identity, origin and conditions before reading an effect as universal. A result from one line or preparation requires further evidence before it can describe a whole organism. Replication in another model can strengthen understanding, but does not erase differences between the models.
Omics measurements are organised collections
Transcriptomics research examines RNA across a biological system. Transcriptome analysis interprets the collected RNA measurements, while RNA sequencing is one approach used to obtain sequence-related evidence. RNA expression usually describes the production or measured abundance of RNA, with the exact meaning determined by the method.
Check what was counted, how values were normalised, and which samples were compared. A list ranked by statistical significance is not a ranking of biological importance. The proteomics guide explains similar distinctions for protein identification and abundance.
From mechanism to a bounded conclusion
Make a four-part note: model, intervention or comparison, measurement, and interpretation. Put proposed mechanisms in a different sentence from the direct observation. If a pathway was inferred from a database, retain that provenance instead of describing every connection as experimentally measured.
For figures, start with microscopy methods or flow-cytometry plots. For molecular diagrams, use protein structure and cell signalling. These reading distinctions do not establish the performance of any catalogue product.
Sources and further reading
Sources checked 25 September 2026: NHGRI: genomic glossary; NHGRI: epigenetics; NHGRI: RNA.
Choose the correct denominator for pathway enrichment
Pathway enrichment compares a selected gene set with a specified background. The background should represent the genes that could have entered that selection, rather than automatically including every known gene. The Gene Ontology enrichment guide recommends recording an appropriate reference list and retaining the analysis settings.
In an original illustration, 20 of 100 selected genes have a particular annotation. Among 1,000 measurable background genes, 100 have it. The proportions are 20% and 10%, giving a descriptive two-fold enrichment. If a different background contains 10,000 genes with the same 100 annotated genes, its proportion becomes 1% and the descriptive ratio becomes twenty-fold. The selected list did not change; the comparison did. Neither ratio is a significance test.
A reproducible reading note includes species, identifier system, background, selection rule, annotation release and multiple-testing method. Check unresolved identifiers rather than silently dropping them. A statistically enriched annotation supports a statement about that comparison; it does not show that every gene in a pathway was measured, that the pathway was activated, or that a treatment works.
Cell identity and contamination answer different questions
Cell-line authentication asks whether the material has the expected identity. Contamination testing asks a different question about unwanted material in the culture. A reassuring result for one does not establish the other. ATCC authentication recommendations explain identity testing, including the use of short tandem repeat profiling for human cell lines.
An invented paper might state that its cells came from a recognised repository several years earlier. That is a provenance statement, but it does not tell the reader what was checked in the cultures used for the reported experiments. Conversely, a recent identity result would not establish the absence of every contaminant or prove that the model represents the tissue under investigation.
Look for the cell-line identifier, source, authentication method and timing, contamination checks, and the passage range used. Record omissions as limitations of the report. When studies use different lines, first ask whether their models answer the same biological question before comparing effect sizes. This is a guide to evaluating published information, not instructions for culturing, modifying or administering cells.
Count independent samples before counting readings
Biological replication represents independently obtained biological material. Technical replication repeats a measurement or processing step on that material. Both can be useful, but they answer different questions about variation. Nature's guidance on replicates makes this distinction explicit.
An original example uses four independently collected specimens, each measured in three wells. There are twelve well readings, but only four independent specimens. If the scientific comparison is between specimens, reporting twelve independent biological replicates exaggerates the amount of independent information. Repeating one specimen many times can reveal measurement variability without revealing how much people or organisms differ.
Draw the sampling hierarchy before accepting an error bar: organism or donor, specimen, preparation, then repeated reading. Note which level was assigned to a condition and which level appears in the analysis. A hierarchical or repeated-measures analysis may be needed when observations share an origin. The appropriate model depends on the design; adding the word replicate to every reading does not make those readings independent.
What should support a qPCR reference-gene choice?
Relative qPCR compares a target signal with a reference measurement. The reference is intended to help account for relevant variation in material and processing, so its behaviour in the studied conditions matters. Calling a gene a housekeeping gene does not demonstrate that its expression remained stable. The original MIQE reporting guidelines ask for justification of reference-gene selection and information about amplification performance.
Imagine a fictional experiment in which both the target and the chosen reference change between conditions. Dividing one by the other can conceal a target change or produce an apparent difference that depends on the reference. The interpretation therefore needs the reported normalisation method, not only a final fold-change bar.
Look for evidence supporting reference stability in the actual specimens, the number of reference genes used and how their measurements were combined. Retain assay efficiency and specificity information because a calculation's assumptions belong with its result.
This question differs from comparing raw RNA-sequencing counts: the concern here is the reference and assay behaviour in a qPCR measurement. It is an appraisal of the report, not an executable amplification protocol or a universal recommendation for particular reference genes.
Can a DNA-content histogram identify every cell-cycle stage?
A DNA-content histogram groups cells by the amount of DNA measured at a particular observation. G0/G1 and G2/M are combined labels because DNA amount alone does not distinguish every stage within them. Thermo Fisher's cell-cycle measurement overview shows these distributions and how an additional mitotic marker can provide a different distinction.
One measurement problem is that two G0/G1 cells recorded together can resemble a single event with a larger DNA amount. BD's DNA analysis documentation explains why distinguishing doublets from single G2/M cells matters for the estimate. A larger high-DNA peak therefore deserves a measurement check before a biological explanation.
For an invented report comparison, one paper excludes documented doublets and another does not describe their handling. Different estimated G2/M proportions could partly reflect that difference. The plots alone cannot identify how much of any difference is biological.
Retain the cell model, DNA measurement, single-event selection, phase model and any additional markers. A snapshot proportion also does not directly measure how quickly individual cells traverse a phase. Interpret a claim about cell-cycle progression using the time-dependent evidence supporting it, rather than treating every histogram change as faster division.
Does co-immunoprecipitation prove direct protein binding?
Co-immunoprecipitation can recover a target protein together with other material associated with it. That supports a question about a complex under the extraction and capture conditions, but it does not by itself establish direct contact between every recovered pair. Thermo Fisher's interaction-assay troubleshooting guidance explicitly distinguishes direct interaction from an association mediated through another protein.
Consider three fictional proteins, A, B and C. If A binds B and B binds C, capturing A may also recover C. A figure showing A and C together is therefore compatible with a bridge through B. It does not identify the binding interface or demonstrate an A-to-C contact.
When reading the experiment, distinguish input material, target recovery and background controls. Note whether the proteins were endogenous or overexpressed, and whether a second method addressed direct interaction. A reciprocal capture can strengthen an association while leaving the direct-contact question unresolved.
A negative capture is also conditional: an association may not survive the reported preparation. Summarise what the method actually recovered and which alternatives its controls address, rather than translating every band into a complete interaction mechanism.
What does an input control add to a histone ChIP-seq result?
Histone ChIP-seq enriches DNA associated with a targeted histone feature, then locates the recovered fragments in a reference genome. An input control helps characterise the material available before the antibody-directed enrichment. The ENCODE histone ChIP-seq standards pair each experiment with a corresponding input control and require antibody characterisation. Those checks address different possible weaknesses.
Suppose a fictional genomic region has a large read signal in both the enriched material and its input. The raw peak alone is less informative than its relationship to the control. More sequencing reads cannot replace understanding why that region was abundant in the starting material.
For a reading record, preserve the histone target, antibody evidence, cell or tissue source, biological replicates, input pairing, genome assembly and peak-calling approach. Check whether comparisons concern narrow or broad enrichment patterns rather than treating every feature as the same kind of peak.
Enrichment is not equivalent to measuring the activity of a nearby gene. A claim about expression needs the relevant expression evidence, and a claim about causation needs additional design support. This control-focused interpretation does not provide a ChIP-seq operating protocol or establish that one mark determines a cell's behaviour.
Does faster gap closure show that individual cells moved faster?
Not necessarily. In a cell migration experiment, the shrinking area of an empty gap can reflect both movement and an increase in cell number. A primary study of exclusion-zone assays demonstrates why proliferation complicates an interpretation based only on the cells entering that space. The visible endpoint and the biological process being claimed are not identical.
Imagine two cultures starting with comparable gaps. After the same observation period, one gap is smaller, but that culture also contains substantially more cells. The photographs establish a difference in gap closure. Without evidence separating division from displacement, they do not establish that each cell travelled faster. Counting how many cells crossed a boundary and following the paths of individual cells answer different questions.
A useful reading record includes the initial gap, starting cell density, observation times, method used to quantify closure and the evidence addressing proliferation. Also retain how the gap was made: mechanical damage and a removable barrier can leave different starting conditions. State the measured result first, then the interpretation supported by those controls. A two-dimensional culture observation does not on its own demonstrate tissue repair or wound healing in a person.
Can a lower apoptosis-marker signal at a later time mean that fewer cells died?
A later, lower signal does not establish that conclusion by itself. Apoptosis measurements follow biological events that change with time. The NIH Assay Guidance Manual describes caspase activity and membrane-related markers as observations of different aspects of that process. A marker can rise and subsequently fall as cells progress through death and lose membrane integrity.
Consider an illustrative graph in which a caspase signal rises at the middle observation and falls at the final one. Reporting only the final point as less apoptosis would discard the earlier response. A parallel observation of membrane integrity, cell number or another relevant marker can help distinguish a weaker response from a response that happened earlier. It still needs interpretation in the particular model.
When reading an apoptosis paper, keep the marker, time after exposure, cell model and measurement method together. Check whether the report follows a time course or observes only an endpoint, and whether its controls address assay interference. A membrane-damage measurement alone does not identify every route to cell death. The aim is to describe which events were actually observed, not to assign a mechanism or a health effect from one fluorescence or luminescence value.
Does detecting an intended CRISPR edit show that every cell has only that edit?
No. Detecting the intended sequence change answers a narrower question than establishing the complete genetic state of every cell. The NHGRI account of genome-editing concerns distinguishes unintended changes at other sites from mosaicism, where cells do not all carry the same edit. A result at the intended location cannot exclude either possibility elsewhere in the material studied.
For an invented example, a bulk measurement detects the desired edit in a mixed culture. The observation does not reveal whether all cells contain it or whether different cells contribute different sequences. Equally, examining a small set of predicted off-target locations only reports on those examined locations and the detection limits of that method. It does not constitute an unrestricted search of every possible change.
Read the validation statement alongside the unit tested: a mixed population, an isolated clone or another defined material. Preserve what was measured, which regions were examined and the limits acknowledged by the authors. Sequence confirmation and an observed change in cell behaviour remain separate lines of evidence. These distinctions help assess a research model; they do not establish that an edited material is suitable for treatment or that a method is free from unintended effects.
Why can the same genetic variant have different reported coordinates?
A genomic coordinate belongs to a particular reference assembly. When a major assembly changes, a position can move without the biological variant becoming a different event. The Genome Reference Consortium documentation distinguishes major assemblies from patch updates and recommends an unambiguous assembly identifier. A chromosome number and position without that context can therefore be insufficient for comparing records.
As an original reading example, two tables describe a change from one base to another but assign it different positions. Before declaring a discrepancy, compare the assembly names, sequence accessions and versions. A conversion between assemblies is a mapping step that should be recorded, with any unresolved location retained rather than guessed. Similar-looking coordinates do not by themselves prove that two records identify the same variant either.
A reproducible genome-analysis note keeps the reference, chromosome or sequence accession, position, reference and alternative sequence, and the annotation version together. Transcript-level descriptions require their own reference transcript context. Matching the identifier is distinct from evaluating the variant's consequence: a coordinate conversion cannot show whether a change affects a protein, explains a phenotype or has clinical significance. This is a record-comparison exercise, not personal genetic interpretation.
Supporting references: NCBI: human genome reference resources.
Can RNA splicing change while total expression of a gene stays similar?
Yes. A gene-level total combines information that may come from different transcripts. A change in the relative use of an exon can occur without a similar change in the total for the gene. The original DEXSeq methods paper treats differential exon usage as a distinct question from overall expression. The unit being compared belongs in the interpretation.
Imagine two illustrative transcript forms contributing 80 and 20 units in one condition, then 20 and 80 in another. Both totals are 100, although their mixture has reversed. A gene-level plot could therefore appear unchanged while an analysis retaining the forms identifies a difference. Actual RNA-sequencing data are more complicated than these units: read assignment, transcript annotations and sampling uncertainty must be considered before making such a claim.
A reading note should identify whether results concern genes, transcripts, exonic regions or splice junctions. Preserve the annotation version and the comparison model, and ask whether the analysis separates usage from overall abundance. A change in exon usage does not by itself demonstrate a corresponding protein form or a functional effect. Those further statements require their own observations. This helps read a splicing result without treating every expression plot as the same analysis.
Does higher oxygen consumption necessarily mean greater ATP production?
An oxygen-consumption reading is not a direct ATP-production total. Mitochondrial respiration can support ATP synthesis, but its interpretation also depends on coupling and other oxygen-consuming processes. The methodological discussion by Brand and Nicholls explains why respiratory control and the response to energy demand matter when assessing mitochondrial function. A single basal value leaves several explanations open.
Consider a fictional comparison in which two cell preparations have different oxygen-consumption rates. Before calling the higher rate more efficient, ask whether they contain comparable numbers of viable cells, whether their energy demands differ and what the experiment establishes about ATP-linked respiration. A larger preparation can consume more oxygen without its individual cells working differently. Increased use of oxygen also need not mean that more of its associated energy is captured in ATP.
Keep the preparation, measurement conditions, normalisation and stated components of respiration beside the graph. An ATP concentration is another separate quantity: a pool size reflects production and use together, whereas a flux concerns a rate. A result should identify which of those was measured. These distinctions support interpretation of mitochondrial experiments; they cannot establish improved human energy, wellbeing or performance from a laboratory oxygen trace.
Do undifferentiated-cell markers alone demonstrate pluripotency?
The undifferentiated state and the capacity to form different lineages are related but distinct properties. ISSCR research standards explain that expression of commonly used markers cannot, on its own, establish pluripotency. The capacity to differentiate needs functional evidence rather than being inferred solely from how an undifferentiated culture looks or stains.
Imagine a new cell line with a familiar marker pattern but no reported differentiation assessment. The marker observations can be recorded as evidence about its current state. They do not establish the complete range of cell types the line can produce. Conversely, a differentiated culture requires evidence about what it has become; the loss of an undifferentiated marker alone does not identify the resulting lineage.
When reading stem-cell biology, separate line identity, current state, genomic characterisation and demonstrated differentiation capacity. Record the assay, combinations of observations and when they were made relative to the experiment. Existing evidence about an established line should be connected to the actual material used rather than silently assumed to apply to every changed culture condition. These are distinctions for evaluating a research model. They do not show that a cell preparation can repair tissue in people or is suitable for therapeutic use.
Do two heterozygous variant calls reveal whether the variants are on the same chromosome copy?
Two heterozygous calls describe variation at two locations but do not necessarily establish their arrangement across chromosome copies. A haplotype groups variants along one copy, as described by the NHGRI glossary definition of haplotype. Phasing supplies information about that arrangement. Without it, a list of variants can leave more than one configuration consistent with the observed calls.
For an invented example, consider a diploid region with alternative variants A and B. One possible arrangement places both alternatives on one copy and neither on the other. Another places A on one copy and B on the other. Both can produce heterozygous calls at the two positions, even though the arrangement differs. This example concerns the logic of the record and does not assign an effect to either variant.
In a genotype-analysis report, look for whether phase was directly supported by the data, inferred using a stated method, or left unresolved. Keep reference assembly and allele descriptions with the result. Do not turn an unphased pair into a definite same-copy or different-copy statement merely because the variants share a gene name. Whether an arrangement matters biologically is a further evidence question; phase alone does not establish pathogenicity or a treatment implication.
Supporting references: NHGRI: Human Genome Reference Program.
Could a mixed single-cell RNA profile come from two captured cells?
A recorded single-cell profile is a technical observation, and its label does not guarantee that only one cell contributed RNA. The original Scrublet paper examines doublets, in which two cells contribute a merged transcriptome. Such profiles can complicate identification of populations, particularly when their contributors have different expression patterns.
Suppose a fictional cluster contains markers normally associated with two distinct populations. A new transitional state is one possible biological interpretation, but a mixture created during capture is another explanation to examine. A doublet score estimates compatibility with a detection method's model; it is not a direct observation of how many cells entered the capture event. A low score also does not prove that every retained observation is a single cell.
Useful analysis notes retain the capture method, expected loading context, detection approach, decision threshold and how exclusions affect the result. Check whether the claimed population persists under a justified sensitivity analysis and whether independent observations support its identity. The interpretation should distinguish a suspected technical mixture from an established biological state. This is a guide to reading quality decisions, not a universal threshold for removing observations from every single-cell dataset.
Top comments (0)